DS Investigational Site 517 — Washington D.C., District of Columbia

DS Investigational Site 517 is a clinical research site located in Washington D.C., District of Columbia, United States 20037.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

DS Investigational Site 517 has participated in 1 clinical trials.

Therapeutic areas: Atopic Dermatitis.

Sponsors: DS Biopharma.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DS Investigational Site 517?

DS Investigational Site 517 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DS Investigational Site 517 conducted?

DS Investigational Site 517 has 1 clinical trials on record. Their work covers Atopic Dermatitis.

Is DS Investigational Site 517 accredited by Crixeo Health?

DS Investigational Site 517 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about DS Investigational Site 517?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.